Yearly Archives: 2024

iNews The findings from Community Pharmacy England’s 2024 Pharmacy Advice Audit, released today, highlight that pharmacies are providing several million walk-in consultations each year. Our report shows the scale of underfunded work pharmacies are taking on, including the number of GP appointments they are saving the NHS annually, and the huge demand pharmacies in England [...]

The post Pharmacies are saving the NHS 38 million GP appointments a year appeared first on Community Pharmacy England.

Community Pharmacy England has released a series of resources to help further promote the Flu Vaccination Service to patients and members of the public. Community pharmacy owners and their teams are working extremely hard to provide the flu vaccination service in a more compressed time scale this year. The change in the timing follows clinical [...]

The post Flu vac: resources to promote the service appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Information: Parasolve (Paracetamol) 500mg effervescent tablets (Kent Pharma UK) Drug alert number: EL (24)A/51 Date issued: 28 October 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Parasolve (Paracetamol) 500mg effervescent tablets (Kent Pharma UK) Company name: Kent Pharma UK Product [...]

The post MHRA Class 4 Medicines Defect Information: Parasolve (Paracetamol) 500mg effervescent tablets (Kent Pharma UK) appeared first on Community Pharmacy England.

As we celebrate Black History Month, we recognise the important contributions of Black colleagues across our sector. This month honours Black history, achievements and experiences, but it has also provided us a time to reflect and reaffirm our dedication to equality, diversity, and inclusion (EDI). Our Chief Executive Janet Morrison said: “At Community Pharmacy England, [...]

The post Honouring Black History Month and EDI appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 3 October 2024) has been published and includes articles on: GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse. Insulin pumps and continuous glucose monitoring (CGM) equipment: guidance for users on [...]

The post MHRA: Drug Safety Update: October 2024 appeared first on Community Pharmacy England.